| Name
|
DABCYL-TNF-a-EDANS (-4 to +6), human
|
| Code
|
[396716-14-6]
|
| The alias
|
DABCYL-TNF-a-EDANS (-4 to +6), human
|
| Sequence (single letter abbreviation)
|
Dabcyl-LAQAVRSSSR-EDANS
|
| Sequence (three-letter abbreviation)
|
DABCYL-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-EDANS (trifluoroacetate salt)
|
| A basic description
|
Synthesized substrate cleaved specifically at the Ala-Ser bond in order to liberate the C-terminal peptide-EDANS fragment from the proximity quenching effect of the DABCYL group, thus representing the first fluorescence-based assay of the herpes virus proteases and permits the characterization of potential inhibitors.
|
| solubility
|
|
| The molecular weight
|
1573.8
|
| Chemical formula
|
?C70H104N22O18S1
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
A.J. H.Gearing et al., Nature , 370, 555 (1994)
K.M. Mohler et al., Nature , 370, 218 (1994)
Becker BF, et al.Biol Chem 383, 1821-6 (2002)
Mohler KM, et al., Nature 370, 218-20. (1994)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|